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Abstract
Background: Making data available as Linked Data using Resource Description Framework (RDF) promotes
integration with other web resources. RDF documents can natively link to related data, and others can link back using
Uniform Resource Identifiers (URIs). RDF makes the data machine-readable and uses extensible vocabularies for
additional information, making it easier to scale up inference and data analysis.
Results: This paper describes recent developments in an ongoing project converting data from the ChEMBL
database into RDF triples. Relative to earlier versions, this updated version of ChEMBL-RDF uses recently introduced
ontologies, including CHEMINF and CiTO; exposes more information from the database; and is now available as
dereferencable, linked data. To demonstrate these new features, we present novel use cases showing further
integration with other web resources, including Bio2RDF, Chem2Bio2RDF, and ChemSpider, and showing the use of
standard ontologies for querying.
Conclusions: We have illustrated the advantages of using open standards and ontologies to link the ChEMBL
database to other databases. Using those links and the knowledge encoded in standards and ontologies, the
ChEMBL-RDF resource creates a foundation for integrated semantic web cheminformatics applications, such as the
presented decision support.
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Background
The current scientific data deluge, in which datasets grow
faster in size and complexity than scientists can keep
up with, defines several new challenges for information
systems. Scientists wish to discover new, unique, and
significant patterns in datasets that explain biological phe-
nomena not yet understood. The discovery of new pat-
terns showing the causes and effects of various biological
phenomena is often beyond the scope of single datasets.
For example, systems biologists integrate micro-array dif-
ferential expression datasets to biological pathways, using
various other datasets to provide evidence for the links [1].
Another prominent example is drug discovery, in which
a new unique chemical entity is designed or discovered
based on a description of its required biological proper-
ties. This process requires the effective linkage of many
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scientific datasets that are both sparse and are growing
independent of each other [2-4].
ChEMBL contains descriptions for biological activities
involving over a million chemical entities, extracted pri-
marily from scientific literature. This provides a unique
resource for drug researchers [5,6]. It is updated on a fairly
frequent basis as the existing data is further curated and
new data is added. The ChEMBL dataset is available for
download and can be browsed using a web interface and
web services. The former requires scientists to import
the data into a relational database, while the latter limits
machine access to the data. ChEMBL also provides web
services for programmatic access, but these are limited to
the specific types of queries which are encoded in the web
service API.
Using the right to download, modify, and redistribute
the ChEMBL data, two independent teams have previ-
ously mapped the ChEMBL relational database to the
Resource Description Framework (RDF), resulting in
Chem2Bio2RDF [7] and ChEMBL-RDF [8]. RDF is a
framework where knowledge is represented by small so-
called triples, reflecting “facts”. A fact can be given on any
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topic, and RDF therefore talks about things very gener-
ically [9]. Things in RDF are represented by resources
named with Uniform Resource Identifiers (URI). When
the URI can be resolved, for example using the HTTP
protocol, it creates linked data [10]. RDF is developed
as an open standard by the World Wide Web Consor-
tium, and provides a knowledge representation frame-
work that applies to many, if not all, domains, and
has been used successfully to integrate data for the life
sciences.
This paper presents an update on the ChEMBL-RDF
data set, including details of the latest structures and
ontologies used to map ChEMBL to RDF, along with new
use cases, showing links to other datasets using their RDF
linked data URIs to further support research in the life
sciences.
Methods
The ChEMBL version used in this paper is ChEMBL 13,
which was released on 29 February 2012. The SQL data
dump provided by ChEMBL was inserted into a local
MySQL database. A set of SQL queries were then exe-
cuted to generate RDF triples using a set of PHP scripts.
The scripts use SQL to query the database and output
triples using print statements. Custom PHP scripts have
been used as a lightweight solution to provide a Linked
Data API via a Apache webserver, as well as to create
data files with triples. These scripts are Open Source
and are available from the source code hosting service,
GitHub [11]. This process has been outlined in a best
practices note by the W3C Health Care and Life Sciences
Interest Group [12]. This process is similar to its original
description.
However, the previous ChEMBL-RDF conversion used
custom predicates and classes to represent RDF triples,
defining an ad hoc ontology [8]. This implicit ontology
reflects the concepts expressed in the relational database,
and is not formally defined. The current version, instead,
uses community-proposed ontologies, making the result-
ing RDF triples more interoperable with RDF provided by
other life sciences databases. The new triple dataset uses
standard ontologies including the Bibliography Ontology
[13] and the Citation Typing Ontology (CiTO) [14] for lit-
erature references and citations, and domain ontologies
such as the Protein Ontology[15] and the Chemical Infor-
mation Ontology [16]. Throughout this paper various
prefixes are used to denote different ontology namespaces
to simplify the RDF examples. These prefixes are outlined
in Table 1.
To expose the ChEMBL-RDF data two approaches have
been adopted. First, a SPARQL endpoint is being hosted
at Uppsala University, using the Open-Source Edition
of the Virtuoso software [19]. Usage is free, but the
allowed volume of querying is capped, based on the
Table 1 Prefixes and their matching namespaces used in
this paper
Common vocabularies
bibo Bibliography Ontology [13]
http://purl.org/ontology/bibo/
chebi Chemical Entities of Biological Interest [17]
http://purl.org/obo/owl/CHEBI#
cheminf Chemical Information Ontology [16]
http://semanticscience.org/resource/
cito Citation Typing Ontology [14]
http://purl.org/spar/cito/
obo / pro OBO & PRotein Ontology [15]
http://purl.obolibrary.org/obo/









estimated computational effort. Second, resources have
been made dereferencable via the http://linkedchemistry.
info resource. The Kasabi platform [20] was used for a
period of time, until that project was discontinued. The
Uppsala SPARQL endpoint still uses resource URIs based
on the Kasabi approach, following a similar URI pat-
tern where linkedchemistry.info/chembl is replaced by
data.kasabi.com/dataset/chembl-rdf.
Although many parts of the ChEMBL-RDF 13 dataset
now use community based ontologies, some terms from
the previous ad hoc ontology are still used when a com-
munity alternative is not yet available. These terms were
created under the URI namespace http://rdf.farmbio.uu.
se/chembl/onto/#, and are referenced here using the pre-
fix: chembl.
Results
We present here the updated ChEMBL-RDF, including a
description of the mapping process and the identification
of links to other datasets. Because the primary purpose
of this paper is to expose the ChEMBL data as linked
data, less focus has been placed on ontologically captur-
ing the fine details of the pharmacological literature. This
is the reason why many concepts are not mapped to exist-
ing ontologies, though also the lack of ontologies with a
clear open license, as defined by the Open Definition [21],
restrict the options.
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Data Structure
For each of the common resource classes, a triple pattern
was defined, following the data available in the relational
database. Unless the ontological meaning of the data in
the database was very clear, the classes are annotated with
concepts as implicitly defined by the relational database.
For example, the activity concept in the triples merely
follows the activity table in the database. As such, the con-
cept of chembl:Activity is implied by the content of that
table in the relational database.
However, where the database content is well-defined,
specific ontologies have been used. For example, where
the database specifies literature from which data were
extracted, the CiTO ontology is used. The choice of the
ontologies is driven by the use cases and compatibility
with other Linked Data projects, rather than formal onto-
logical considerations. We have not observed ontological
contradictions based on these choices.
Figure 1 shows how the various resource classes are
linked together, detailed in this section at a triple level.
The core concept in the ChEMBL database is that of
the biological activity. While ChEMBL provides both the
original activities as found in literature and standardized
values allowing comparison between studies, the triples
only make the latter available. The links to the literature
are encoded using the CiTO ontology. This results in a set













More than five thousand different activity types, rep-
resented by the chembl:type predicate, are captured by
the ChEMBL database. The top five types are “Potency”
(43%), “IC50” (13%), “MIC” (4.6%), “Inhibition” (3.7%),
and “Ki” (3.6%). The activity types in ChEMBL-RDF are
currently not available as, or linked to, an ontology. The
BioAssay Ontology could be a future option [22].
The activities themselves are measured against assays,
which make up a second important resource type. Various









"Inhibition of ... hydroxylase" .
Each assay measures activities against one or more
























Figure 1 The various resource types found in the ChEMBL-RDF triples. Some entities are subclasses of common classes, using a rdfs:subClassOf
predicate, such as target:t100122, while others are instances using the rdf:type predicate, such as assay:a17. The predicates between classes are also
provided, showing how the resources are semantically linked.
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database associates a confidence score (see the Com-
pound Selectivity example). Because this score is specific










chembl:UNCHECKED, and chembl:UNKNOWN. The lat-
ter two are currently defined as explicit types, thus effec-
tively implementing a closed-world approach.













"Membrane" , "Sulfation" ;
chembl:organism "Homo sapiens" .
For drug discovery, the drug-like compounds them-
selves are the main topic of study. ChEMBL contains
many different compound types, mostly small molecules,
but also peptides, proteins, antibodies, oligosaccharides,
oligonucleotides, and even cells. ChEMBL-RDF follows
the approach used by the CHEMINF ontology, and
encodes drugs as classes, rather than instances, and they
subclass other classes defined by several ontologies for
these types. For example, protein drugs subclass the Pro-
tein class from the PRotein Ontology (PR_000000001),
instead that these drugs are of the Protein type. Each
drug is a class itself. Likewise, small molecules sub-
class the Chemical Entity class from the CHEMINF
ontology (CHEMINF_000000) (which is itself equivalent
to the Chemical Entity class in ChEBI, CHEBI_24431),
and oligosaccharides and oligonucleotides subclass their
respectivematches in the CHEBI ontology (CHEBI_50699
and CHEBI_7754). To ensure that we can look up all
entities for which activities are reported, we subclass
everything from the BFO 1.1 class MaterialEntity [18],
which is a superclass of the CHEMINF Chemical Entity
class.
It should also be noted that all drug-like entities in
ChEMBL are not ontologically subclassing a drug class.
Instead, we give the entities the role of drug, and only
within a particular context would they be a drug. If not
used as a medication, they are not a drug. Moreover, the
triples only attach this drug role to approved drugs, as
defined by the ChEMBL database. The role is triplified
using the OBO and ChEBI ontologies in the following
manner, where CHEBI_23888 is the ontological entry for
“drug role” in ChEBI:
mol:m4 obo:has_role chebi:CHEBI_23888 .
The name and synonyms for each drug are provided
as labels. If SMILES, InChI, or InChIKeys are given for a
drug, then these are provided via the CHEMINF formal-
ism. The CHEMINF ontology has been used here because
of its flexibility in defining descriptor types and their ori-
gin and meaning. By allowing an ontology of descriptors,
we enable the comparison of values between databases
semantically. Differences in, for example, the SMILES
string may then be explained by the software used for that
descriptor.
Example output for ChEMBL406142 looks like:
mol:m41
rdfs:label "ChEMBL406142" ,
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Similarly, the properties of small molecules are avail-
able from ChEMBL, and as of ChEMBL-RDF 13 these
too are exposed in triple format. Like the InChI and
InChIKey, these are provided using the CHEMINF ontol-
ogy. Here is, for example, the logP value (as dis-








The literature from which all this data was extracted, is
replicated from the database, but only a subset of the pos-
sible information about that literature is provided. In all
cases the PubMed Identifiers (PMIDs) and Digital Object
Identifiers (DOIs) are used to link to an authoritative
database, as outlined later in this paper. The properties
are provided using the BIBO ontology, which is an open
source ontology for bibliographic information, compatible















dc:title "J. Med. Chem." .
Data statistics and validation
Each release of the ChEMBL database is accompanied by
a set of release statistics which help provide a concise con-
tent overview of the release in question. The ChEMBL 13
release counts are as follows:
• 8,845 targets




These counts are important as firstly they show con-
tinued growth in ChEMBL data, as seen in all previous
releases. Secondly, these counts can help validate any
transformations, which have been applied to the relational
data model traditionally used to store the ChEMBL data.
The following SPARQL queries attempt to provide a high
level validation of the ChEMBL-RDF by regenerating the
ChEMBL 13 release statistics.
The following SPARQL query returns 8,845 ChEMBL
targets:
select count(*) WHERE {
?s ?p chembl:Target .
}
A similar SPARQL query, replacing chembl:Target
with bfo:MaterialEntity, returns 1,143,682 enti-
ties for which activities are captured in ChEMBL, and
by using chembl:Assay, the query returns the total
of 617,676 ChEMBL assays. It should be noted that
this last query returns five entries less than the SQL
database, because the triple generation requires the assay
type to be defined, which is not the case for those five
assays. With chembl:Activity and bibo:Article,
we count 6,933,068 ChEMBL activities and 44,681 doc-
uments, respectively. The document count is one fewer
than appears in the ChEMBL 13 release notes [23],
as the result does not include the doc_id -1, as this
refers to the unpublished dataset, which is not a valid
bibo:Article.
Reproduction of the ChEMBL release statistics through
querying ChEMBL-RDF with SPARQL provides end users
with a high degree of confidence that the ChEMBL-RDF
contains the same core content as the source relational
database. The development of a validation test suite is
being discussed but not yet implemented; testing crite-
ria other then the summarizing counts presented here,
would change with each release due to curation events.
Interactive, manual curation of the conversion process as
employed by the authors already is more effective at this
moment.
Linked open data
To integrate ChEMBL-RDF with RDF versions of other
scientific datasets, we link out to various resources. These
links are shown in Figure 2. Triples for compounds link
out to ChemSpider using the complementary index and
OpenMolecules RDF using InChI values [8,24,25]. Protein
links are given to Bio2RDF [2] using the UniProt iden-
tifier [26]. Literature references are directed to CrossRef
and Bio2RDF using the DOIs and PubMed identifiers,
respectively [27].
The predicates used to capture the links to these
databases are rdfs:seeAlso, skos:exactMatch,



















Figure 2 The links out of the ChEMBL-RDF data into the Linked
Open Data cloud versions of various external databases. Edges
are labeled by the predicates making the links.
owl:equivalentClass, and owl: sameAs. These
relations are ordered according to their increasing level
of implication: ranging from “you may also be interested
in” with rdfs:seeAlso to “both objects are identi-
cal and all properties apply to both objects” for owl:
sameAs.
Linking out to Bio2RDF
The Bio2RDF project provides both resolvable Linked
Data URIs using a generic Linked Data server [28] and
SPARQL endpoints containing RDF data from a range of
scientific databases [2]. A number of these databases are
referenced in ChEMBL, including ChEBI, PubMed, and
both the UniProt protein and taxonomy databases [26].
These links are vital to provide context for use cases that









For resources from the biomedical with PubMed identi-
fiers we also link out to Bio2RDF:
res:r23 skos:exactMatch <http://
bio2rdf.org/pubmed:15149661> .
Linking out to ChemSpider
ChemSpider [24] is a freely accessible, online database
provided by Royal Society of Chemistry (RSC). It con-
tains over 28 million unique chemical compounds aggre-
gated from over 400 data sources, as well as chemical
data extracted from RSC scientific articles and databases.
Since its inception, efforts have been made to utilize it
as both a deposition platform for the community to con-
tribute novel data, as well as a platform for annotation
and curation for existing data. ChemSpider has become
a valuable resource for curated data, especially chemical-
compound name mappings [29]. ChemSpider is presently
providing the chemical structure, substructure and simi-
larity searching services underpinning the Open PHACTS
semantic web project [4]. Specific chemical data sources
containing data mappings between ChemSpider identi-
fiers (CSIDs) and the original data source identifiers have
been provided to the triple store, together with chemi-
cal identifiers including validated chemical names (sys-
tematic, generic and trivial), SMILES, and InChIs. The
data mappings between the CSIDs and ChEMBL IDs are
released to the community under the Creative Commons
Attribution, Share Alike, license (CC-BY-SA 3.0). Attribu-
tion should be made to the original ChEMBL database,
Open PHACTS, and ChemSpider.
Link mappings are provided with skos:exactMatch
predicates, while the ChemSpider identifiers are also





Linking out to OpenMolecules RDF
The InChI is a unique identifier for (small) organic
molecules, and has been previously used to define unique
URIs for molecules [8,25]. While URIs are theoretically
unlimited in length, in practice many web browsers and
servers limit the length of URIs. Virtuoso is, unfortu-
nately, one such system that supports only URIs of up to
a certain length. Therefore, InChI-based links are only
created for smaller molecules. Almost 1.1 million links to




Notice here the use of owl:equivalentClass since
in CHEMINF molecules are defined as classes rather than
instances.
Linking out to CrossRef
In addition to the PubMed identifiers used to link from
literature references to Bio2RDF, ChEMBL provides
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ChEMBL-RDF can be used to explore interrelated sci-
entific datasets, and we present here five applications,
describing how the SPARQL endpoint can be used, the
combination of the ChEMBL data with other life sciences
databases, the use of the bibliographic information in cal-
culating citation statistics, and how to integrate ChEMBL-
RDF with ChemSpider to provide an extension for the
decision support platform in Bioclipse.
Bio2RDF
This first application shows how ChEMBL-RDF can be
integrated into other linked data services. The Linked
Data server used by Bio2RDF has been reconfigured for
ChEMBL to provide URL based services for standard
URI resolution, along with textual and link-based searches
[28]. A Java Web Archive (WAR) file along with the
configuration files and build scripts for the ChEMBL-
RDF Linked Data server are available on GitHub [30].
It proxies the standard ChEMBL-RDF URIs by translat-
ing URLs between those requested by users and the URIs
that are available in SPARQL endpoints. For example, if
the ChEMBL web application is running on the user’s
local machine, e.g. http://localhost:8080/chembl/, then a
request for the article with identifier “a31863”, http://
localhost:8080/chembl/article/a31863, will be resolved
using the webapp from the database using the full original
URI, http://linkedchemistry.info/chembl/activity/a31863.
If the user requested an RDF document using content
negotiation, the original URIs will be unchanged, how-
ever, if the user requested anHTML document, the results
will contain both the original RDF triples, represented
using RDFa, with links that resolve using the user’s local
machine.
These link services enable the ChEMBL application to
derive both forward links, originating in ChEMBL, e.g.
http://localhost:8080/chembl/linkstonamespace/-targetns/
originalns:identifier, and backward links, originating
in other databases, such as LODD, Bio2RDF (http://
bio2rdf.org/linksns/targetns/originalns:identifier), and
Chem2Bio2RDF. These services are vital to efficiently
navigate the Linked Data web, as it is both impractical and
inefficient to require users to crawl the entire web before
they can discover relevant resources. These services are
currently only supplied as web services from ChEMBL
and Bio2RDF, but it is hoped that similar services will be
provided by other scientific Linked Data providers in the
future. Datasets that are available in SPARQL endpoints
can be queried for links efficiently using simple queries as
demonstrated in the ChEMBL web application.
Chem2Bio2RDF
A second resource in the linked open data network into
which ChEMBL-RDF was integrated is Chem2Bio2RDF.
Chem2Bio2RDF is a single RDF repository covering over
twenty public data resources pertaining to drugs, chem-
ical compounds, carcinogens, protein targets, genes, dis-
eases, side effects, pathways and their relations [7]. The
entities and their relations were further annotated by
Chem2Bio2OWL ontology, making it a rich semantic
resource for integrative searches [31] and data min-
ing [32]. The ChEMBL-RDF set was uploaded into the
Chem2Bio2RDF triple store, enabling queries linking
ChEMBL with other entities in Chem2Bio2RDF. Since
both ChEMBL-RDF and Chem2Bio2RDF use InChI keys
to present chemical compounds and adopt Bio2RDF pro-
tein identifiers to present targets, queries can be easily
constructed to link the two. For instance, to investi-
gate the relations between drug side effects and their
targets (usually off-target effects), a query was created
to link the targets in ChEMBL to side effects (e.g.,
heart disease) in Chem2Bio2RDF via side effect related
drugs and their bioassay activities. In this case, 36 drugs
causing heart disease were linked to 87 unique pro-
tein targets (IC50 < 10 μm). The top two most com-
mon targets of these drugs are HERG and Serotonin
transporter. HERG is a well-known off-target account-
ing for cardiovascular problems, while the activity of
Serotonin transporter may also be associated with signif-
icant cardiovascular adverse effects [33]. The targets can
also be linked to side effects via protein-protein inter-
actions by searching across ChEMBL, HPRD and SIDER
in Chem2Bio2RDF. Example SPARQL queries are avail-
able at http://chem2bio2rdf.wikispaces.com/Integrate+
with+ChEMBL and can be executed in the SPARQL
endpoint [7].
CitedIn
Using the SPARQL endpoint, it is easy to integrate data
from ChEMBL into other web resources, such as Cite-
dIn (http://www.citedin.org) [34]. While the impact
of a scientific publication is traditionally measured by
frequency of citation in subsequent publications, this
narrowly defined calculation increasingly fails to capture
the true reach of a paper. CitedIn was developed to make
scientific impact more visible and more accurate by pro-
viding insight into where published work is being cited
online in a variety of public resources, as listed on the
CitedIn website [35]. ChEMBL contains many literature
references. The SPARQL endpoint is queried by CitedIn
and the results are presented to its users. Figure 3 shows
the results for the Nature paper by Gamo presenting the
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malaria structures [36] which is cited as the reference
for a large number of activity datapoints and com-
pounds in ChEMBL. Counting all objects that reference
this paper is done by the following SPARQL query
template:
SELECT COUNT(?object) WHERE {




Figure 3 Screenshot of the CitedIn web service showing a 2010 Nature paper cited 94671 times in the ChEMBL database. The Details
button on the webpage links to a ChEMBL webpage with detail on what parts of the database are linked to that paper.
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The CitedIn summary for ChEMBL also provides a
Details button that links back to a ChEMBL webpage pro-
viding a Document Report Card showing in more detail
what targets, assays, compounds, and activities in the
database are linked to that paper.
Bioclipse decision support
The use of the RDF open standard also simplifies the inte-
gration of data resources with scientific software, as we
have shown previously [8,37]. We here demonstrate a new
application following this idea.
Bioclipse Decision Support (Bioclipse DS) [38] is a
user-oriented tool based on the Bioclipse workbench
for providing on-time and on-demand information on
chemical structures. Such information can include calcu-
lated properties, data from database queries, and results
from predictive models. Bioclipse DS has previously
been demonstrated on predictive modeling in drug safety
assessment [38] and also been linked to invoke and
present results from distributed toxicity predictions from
the OpenTox infrastructure [37].
In this study we extended Bioclipse DS with remote
access to both ChEMBL-RDF and ChemSpider. This
enables users browsing chemical structures in Bioclipse to
look up nearest neighbors in ChemSpider via the Chem-
Spider Web API (SOAP), and for the found compounds
to be used to query ChEMBL-RDF for available interac-
tion data. The results are presented alongside predictive
models in Bioclipse (see Figure 4), and can be used for
decision support when evaluating chemical structures and
considering strategies for optimization.
Compound selectivity
Designing a molecule that is selective in binding to one
target rather than another is often considered a success-
ful outcome in a drug design process. If the target in
question is a protein, high sequence similarity between
the binding site and that of other proteins will make
such selectivity more challenging. That is, the molecule
being designed may also bind to the equivalent bind-
ing site in the closely related protein target, and this
may lead to undesirable consequences. The ChEMBL data
model links molecules to targets using different activ-
ity types recorded in the literature. Using activity types
that act as a measure of binding affinity, such as IC50
or Ki, and applying activity value cut-offs, it is possible
to identify molecules which have higher binding affinity
to certain targets compared to others. Taking this one
step further, it is possible to identify a set of molecules
that have a high affinity to protein A (e.g. IC50 value <
50 nM) and low affinity to protein B (e.g. IC50 value >
200 nM).
The following SPARQL query identifies a set of 65
molecules that selectively bind Human Cyclin-Dependent
Kinase 2 (UniProt: P24941) over Human Cyclin-
Dependent Kinase 4 (UniProt: P11802), based on data
curated from the literature and stored in the ChEMBL-
RDF data model.
SELECT DISTINCT ?molecule WHERE {
?target1 owl:sameAs <http://bio2rdf.
org/uniprot:P24941> .
?assay1 chembl:hasTarget ?target1 .






FILTER ( ?value1 < 50 ) .
?target2 owl:sameAs <http://bio2rdf.
org/uniprot:P11802> .
?assay2 chembl:hasTarget ?target2 .






FILTER ( ?value2 > 200 ) .
}
Analysis on the set of molecules returned by this query
can be used to help identify small molecule features,
which may increase target-binding specificity. For queries
which link small molecules to targets, by traversing bioac-
tivity data in the ChEMBL database, it is also important
to consider the parameters associated with the assay to
target mappings. These additional parameters include a
relationship type, a multi flag (for poorly defined targets)
a complex flag (for protein complex targets) and a cura-
tion level. These different factors are summarized in the
ChEMBL confidence score, which ranges from 9 (direct
single protein target) to 0 (uncurated). In order to return
the largest possible dataset, the confidence score has
been ignored in this example compound selectivity use
case.
Discussion
This paper shows the evolution of the ChEMBL-RDF
resource in standardizing access to the ChEMBL data in a
machine-readable manner using semantic web technolo-
gies. We showed here that the conversion into RDF allows
a number of novel integrations with other resources. It
should be clear that these applications can be made using
other technologies too, but using the RDF standards it
is easier to implement them. More importantly, the solu-
tions will be generally applicable to any system using
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these open standards. However, a number of choices need
discussion.
Much could be argued about the choice of ontologies,
and the lack of an ontology in places where we decided
to use custom classes and predicates. Most of the choices
are based on pragmatic approaches to enable solutions
to the range of use cases we describe here. It should be
noted, however, that the ChEMBL database captures a
wide variety of experimental studies and that semantics
are not fully specified in the primary source from which
the ChEMBL data was extracted. As it is not possible to
infer the original intentions in these cases, it is our opin-
ion that it is better to leave some semantics undefined.
During the development of the applications some incor-
rect assumptions have been discovered and fixed, but
in the main we have tried to avoid making assumptions
if they are not generally known to be valid. Therefore,
the goal of this work is the conversion of the ChEMBL
data into RDF, and not an ontological modeling of the
domain.
One case where Linked Data publishers must avoid
implying strong semantics in many cases is in relation
to links to other databases. When linking between two
databases based on a shared identifier, Linked Data pub-
lishers make assumptions including syntax assumptions
that the identifiers are correct and present in the tar-
get database, along with semantic assumptions inferring
that the that entries identified in the target database have
a scientifically meaningful relationship with the current
database. It is for this reason that the ChEMBL-RDF
dataset uses different predicates for linking to various
databases. This problem, however, is general, applying
also to other cases where databases link out to third-party
sources using identifiers [39].
Figure 4 Screenshot from the Bioclipse Decision Support with results from a combined ChemSpider and ChEMBL-RDF search. The top left
canvas contains the query structure, carbamezapine, and the top right canvas shows its near neighbors found in ChemSpider for which
ChEMBL-RDF data exists. The lower right canvas shows the chemical structure selected in the top right canvas, and the lower left canvas shows the
available activities in ChEMBL-RDF for this compound.
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Also debatable is the choice of ontologies used to
describe the dataset in RDF. As an example, in this release
of the ChEMBL-RDF data, we adopted the cheminfor-
matics ontology, CHEMINF. Using this ontology we can
encode numeric and non-numeric descriptors of chem-
ical entities in a consistent manner. This method is
used to consistently expose identity descriptors such as
the SMILES string, InChI, and InChIKey, and molecular
properties including the logP, rotatable bond count, and
hydrogen bond donor and acceptor counts. However, the
design of this annotation is more general than may be
needed for a translation of the data in the ChEMBL rela-
tional database into RDF. Although this results in more
complex SPARQL queries, it allows generic queries that
may not otherwise be easy to construct. While the selec-
tion of ontologies usedwas found to fit well with our appli-
cations, we anticipate that we will select more expressive
ontologies in future iterations of the project.
Some information in the databases has not yet been
annotated using standard ontologies. For example, the
activity types in ChEMBL, such as “IC50”, “EC50”, and
“Potency”, are not exposed in the RDF dataset, meaning
that it is not yet possible to reason or group over sim-
ilar activity types. When the activity types are exposed,
queries could be constructed based on the knowledge that
the IC50 and Ki endpoint are closely related. Similarly,
measurement units are currently provided as string liter-
als, making it difficult to compare concentrations when
some are given in nM and others in mM. In the future
it may also be possible, relying on some assumptions, to
crossmatch activities expressed in μg/ml with query con-
centrations in nM. These additional semantics are neces-
sary to translate raw experimental data into semantically
useful, machine-readable information.
Two ontologies were recently developed that may
address these issues for ChEMBL-RDF in future. Firstly,
the BioAssay Ontology, which addresses many of our
remaining concerns around making the experimental
data machine readable. For example, it provides an
ontology of activity types. Secondly, the Quantity, Unit,
Dimension and Type (QUDT) ontology which makes
it possible to express measurements in a standardised
machine readable way [40]. Both approaches are being
explored in the Open PHACTS project and will be
applied to ChEMBL-RDF as the Open PHACTS project
progresses [4].
Conclusions
Taking these points into account, we believe that the adop-
tion of RDF and community based ontologies allows novel
use cases to be addressed using the ChEMBL data that
would not otherwise be achievable. More importantly, the
adoption of explicit semantics simplifies integration with
other resources, as others can more easily understand the
intent and purpose of each part of the ChEMBL dataset.
This is a requirement which is essential to the efforts of
cheminformatics researchers wishing to infer knowledge
from ChEMBL as well as other datasets.
The ongoing ChEMBL-RDF project is Open Source
making it possible to others to convert ChEMBL to RDF
too. Technically, the choice of PHP makes it easy to
share functionality between the here described conversion
scripts, and PHP-enabled web services, used to provide
the Linked Data interface to the ChEMBL-RDF data, as
is fast enough for practical uses. These scripts do not
use a library for handling RDF data. While using such
libraries increases the dependencies for the scripts, they
also ensure the generation of syntactically correct RDF
triples. Continued development of the ChEMBL-RDF
scripts, however, has started using RDF libraries for this
purpose specifically for triple generation of compound
names, removing code in the scripts to escape special
characters, like double quotes.
Finally, the ChEMBL project will provide RDF versions
of ChEMBL, while others continue exposing ChEMBL as
RDF too (EW, PA). In the future various versions may
arise, exposing the data in different ontologies, support-
ing current community needs, however, convergence is
expected after a period of experimenting with ontologies
that may not prove to be practically useful. The availability
of Open Source scripts ensures that the community can
contribute to the process of choosing a practically useful
set of ontological terms.
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